IRIS
PLAZ TORRES, MARIA CORINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.930
AS - Asia 20
SA - Sud America 9
Totale 1.959
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 1.929
CN - Cina 10
BR - Brasile 8
ID - Indonesia 3
VN - Vietnam 3
SG - Singapore 2
HK - Hong Kong 1
KZ - Kazakistan 1
PY - Paraguay 1
UA - Ucraina 1
Totale 1.959
Salva come PNG Salva come JPEG
Città #
Genoa 994
Genova 542
Vado Ligure 234
Rapallo 151
Bordighera 8
Beijing 3
Singapore 2
Aktobe 1
Bandung 1
Biên Hòa 1
Duque de Caxias 1
Franca 1
Hanoi 1
Ho Chi Minh City 1
Hong Kong 1
Itapeva 1
Kharkiv 1
Maracaçumé 1
Muriaé 1
Ourinhos 1
Ouro Fino 1
Santa Cruz do Capibaribe 1
Totale 1.949
Salva come PNG Salva come JPEG
Nome #
Hepatobiliary and Pancreatic: A rare cause of portal hypertension. 224
Low Fibrinogen Levels Are Associated with Bleeding After Varices Ligation in Thrombocytopenic Cirrhotic Patients 123
Corticosteroid Treatment at Diagnosis: An Analysis of Relapses, Disease Extension, and Colectomy Rate in Ulcerative Colitis 110
Appropriateness of proton pump inhibitors treatment in clinical practice: Prospective evaluation in outpatients and perspective assessment of drug optimisation 110
Mediterranean Diet and NAFLD: What We Know and Questions That Still Need to Be Answered 92
Recalibrating survival prediction among patients receiving trans‐arterial chemoembolization for hepatocellular carcinoma 86
Diabetes Medications and Risk of Hepatocellular Carcinoma 72
Liver Resection for Patients with Intermediate Stage Hepatocellular Carcinoma: Beyond Rigid Staging Systems Towards a More Personalized Therapeutic Approach 70
Is there an "ideal" diet for patients with NAFLD? 70
Surveillance for Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease: Universal or Selective? 68
Global multi-stakeholder endorsement of the MAFLD definition 67
Risk factors for bleeding following oesophageal band ligation: Providing further evidence to ameliorate clinical practice 64
Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma 60
Use of non-invasive scores for the estimation of mortality risk in patients with Non-Alcoholic Fatty Liver Disease 56
Nuts and Non-Alcoholic Fatty Liver Disease: Are Nuts Safe for Patients with Fatty Liver Disease? 56
Letter to the Editor: Is CAD-LT score as a predictor of coronary artery disease following liver transplantation? 52
Obeticholic Acid Improves Aminotransferases Early during Treatment in Patients with Primary Biliary Cholangitis Not Responding to Ursodeoxycholic Acid: A Study in Clinical Practice 51
Albumin-bilirubin score in non-malignant liver diseases should be properly validated 51
Food Intolerances, Food Allergies and IBS: Lights and Shadows 48
Health-related Quality of Life in Patients With Nonalcoholic Fatty Liver Disease: A Prospective Multi-center UK Study. 45
Treatment of Hepatocellular Carcinoma with Immune Checkpoint Inhibitors and Applicability of First-Line Atezolizumab/Bevacizumab in a Real-Life Setting 43
Characteristics and outcome of anti‐hepatitis D virus positive patients with hepatocellular carcinoma 42
From Dysbiosis to Hepatic Inflammation: A Narrative Review on the Diet-Microbiota-Liver Axis in Steatotic Liver Disease 42
Secondary prevention of variceal bleeding in adults with previous oesophageal variceal bleeding due to decompensated liver cirrhosis: a network meta-analysis 40
SAFETY AND EFFICACY OF ATEZOLIZUMAB/ BEVACIZUMAB IN PATIENTS WITH HEPATOCELLULAR CARCINOMA AND IMPAIRED LIVER FUNCTION: A SYSTEMATIC REVIEW AND META-ANALYSIS 40
Hepatocellular carcinoma in patients with Autoimmune Hepatitis 38
Absence of Viral Replication Is Associated With Improved Outcome in Anti‐HCV‐Positive Patients With Hepatocellular Carcinoma 36
Primary prevention of variceal bleeding in people with oesophageal varices due to liver cirrhosis: a network meta-analysis 36
Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept 33
null 30
Towards an integrated management model for hepatocellular carcinoma 30
Reply: novel antidiabetic drugs and the risk for hepatocellular carcinoma. What else to expect from these "wonderful" drug classes? 26
Management and Treatment of Hepatitis C: Are There Still Unsolved Problems and Unique Populations? 25
Immune checkpoint inhibitors in malignancies after liver transplantation: a systematic review and pooled analysis 19
Characteristics and Outcomes of Hepatocellular Carcinoma in Patients with Autoimmune Hepatitis 17
Effects of glucagon-like PEPTIDE-1 receptor agonists on incidence of hepatocellular carcinoma and liver decompensation in patients with diabetes: A systematic review and META-analysis 11
Totale 2.083
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.511
article - articoli 11.168
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.679
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021111 0 0 0 11 7 4 5 30 12 19 3 20
2021/2022181 15 6 1 7 9 9 7 34 31 28 9 25
2022/2023204 20 21 9 2 20 18 14 13 32 11 43 1
2023/2024186 6 18 4 33 19 13 12 14 9 11 19 28
2024/2025720 32 32 21 41 80 80 69 143 33 25 75 89
2025/2026388 124 43 85 136 0 0 0 0 0 0 0 0
Totale 2.083